Public Health
Meth addiction treatments are finally on the horizon
New antibody and drug therapies may soon help treat meth patients, who currently have no pharmacological interventions.
Blood test can find dozens of types of cancer, with few false positives
Grail’s Galleri multi-cancer blood test found multiple cancers in a study of over 6,000 patients.
ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency
A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health.”
Long COVID: Self-targeted immune attacks may lurk behind it
Researchers are working to get a more complete understanding of the cells and antibodies behind long COVID.
San Francisco decriminalizes plant-based psychedelics
San Francisco joins Oakland, Santa Cruz, DC, and Denver in decriminalizing some psychedelics.
How NASA is planning to prevent a Martian plague
When Mars samples arrive, they may carry more than knowledge. To offset the chance of a Martian pandemic, NASA is learning to contain a Red Planet plague.
Breakthrough drug could save hundreds of thousands of children’s lives
A booster dose of the University of Oxford’s malaria vaccine demonstrated up to 80% efficacy in children over a year of follow-up.
Newly discovered antibody neutralizes all variants of the coronavirus
Using modified mouse models originally designed for HIV, researchers have discovered an antibody that stops all known strains of COVID-19.
At long last, we might have an HIV vaccine
Due to HIV-1's extraordinary diversity, a vaccine needs to induce antibodies that can target many different strains.
FDA authorizes updated COVID-19 boosters
The FDA has authorized Pfizer-BioNTech’s and Moderna’s updated COVID-19 boosters, which target the now-dominant Omicron subvariants.